Cas 1004318-33-5,1-benzylamino-3-{benzyl[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}propane

1004318-33-5

Post Buying Request

Basic information

Product Name: 1-benzylamino-3-{benzyl[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}propane
Synonyms: 1-benzylamino-3-{benzyl[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}propane
CAS NO:1004318-33-5
Molecular Formula:
Molecular Weight: 395.525
EINECS: N/A
Product Categories: N/A
Mol File: 1004318-33-5.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-benzylamino-3-{benzyl[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}propane(CAS DataBase Reference)
NIST Chemistry Reference: 1-benzylamino-3-{benzyl[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}propane(1004318-33-5)
EPA Substance Registry System: 1-benzylamino-3-{benzyl[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}propane(1004318-33-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1004318-33-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1004318-33-5 Suppliers

Recommended suppliersmore

1004318-33-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1004318-33-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,4,3,1 and 8 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1004318-33:
(9*1)+(8*0)+(7*0)+(6*4)+(5*3)+(4*1)+(3*8)+(2*3)+(1*3)=85
85 % 10 = 5
So 1004318-33-5 is a valid CAS Registry Number.

1004318-33-5Upstream product

1004318-33-5Downstream Products

1004318-33-5Relevant articles and documents

CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF

-

Page/Page column 117, (2008/06/13)

The present invention features compounds of formula I or pharmaceutically acceptable salts, solvates or prodrugs thereof, and methods of using the same to inhibit the metabolizing activities of CYP enzymes. The present invention also features methods of using these compounds, salts, solvates or prodrugs to improve the pharmacokinetics of drugs that are metabolized by CYP enzymes.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1004318-33-5